Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00009776 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, Davis